{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:23:52Z","timestamp":1770337432303,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.contraception.2009.06.011","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T04:58:11Z","timestamp":1248325091000},"page":"49-56","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of the low-dose combined oral contraceptive chlormadinone acetate\/ethinylestradiol: physical and emotional benefits"],"prefix":"10.1016","volume":"81","author":[{"given":"Marie-Luise S.","family":"Heskamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg A.K.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.06.011_bib1","unstructured":"Society of Consumer Goods Research (Gesellschaft f\u00fcr Konsumg\u00fcterforschung). Survey on prevalence of depressive mood and other psychical disorders in German women. Dec 2005\u2013Jan 2006. unpublished."},{"key":"10.1016\/j.contraception.2009.06.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2004.07.010","article-title":"A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms","volume":"71","author":"Sangthawan","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.06.011_bib3","first-page":"219","article-title":"Influence of chlormadinone acetate on dysmenorrhea and other cycle-related complaints (original in German language)","volume":"8","author":"Bock","year":"2008","journal-title":"Gyne"},{"key":"10.1016\/j.contraception.2009.06.011_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-200222040-00002","article-title":"Contraceptive efficacy and tolerability of chlormadinone acetate 2 mg\/ethinylestradiol 0.03 mg (Belara\u00ae)","volume":"22","author":"Schramm","year":"2002","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.contraception.2009.06.011_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(02)00536-X","article-title":"A 12-month evaluation of the CMA-containing oral contraceptive Belara\u00ae: efficacy, tolerability and anti-androgenic properties","volume":"67","author":"Schramm","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.06.011_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2007.03.014","article-title":"Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study","volume":"76","author":"Schramm","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.06.011_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0010-7824(98)00008-0","article-title":"Efficacy and safety of the new antiandrogenic oral contraceptive Belara\u00ae","volume":"57","author":"Zahradnik","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.06.011_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomised, controlled, parallel phase III trial with EE\/CMA (Belara\u00ae) and EE\/LNG (Microgynon\u00ae)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2009.06.011_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2165\/0044011-200828120-00006","article-title":"Effect of an oral contraceptive with chlormadinone acetate on depressive mood. Analysis of data from four observational studies","volume":"28","author":"Huber","year":"2008","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.contraception.2009.06.011_bib10","series-title":"Premenstrual syndrome","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2000"},{"key":"10.1016\/j.contraception.2009.06.011_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1192\/apt.7.6.469","article-title":"Premenstrual syndrome: an update on definitions, diagnosis and management","volume":"7","author":"Connolly","year":"2001","journal-title":"Adv Psychiatr Treat"},{"key":"10.1016\/j.contraception.2009.06.011_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1024\/0040-5930.58.9.564","article-title":"Cardiovascular risks associated with low-dose combined oral contraceptives","volume":"58","author":"Merki-Feld","year":"2001","journal-title":"Ther Umsch"},{"key":"10.1016\/j.contraception.2009.06.011_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.06.011_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.06.011_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.contraception.2009.06.011_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-201x.1999.00579.x","article-title":"Neuroactive steroids: their mechanism of action and their function in the stress response","volume":"167","author":"Zinder","year":"1999","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.contraception.2009.06.011_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006842-199909000-00010","article-title":"Gonadal steroids in the treatment of mood disorders","volume":"61","author":"Epperson","year":"1999","journal-title":"Psychosom Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T02:23:35Z","timestamp":1545099815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0010782409003114"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.06.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}